Pat Harding

Pat Harding has worked in quality/pharmacovigilance at Lilly for the past 20 years. Her current role is a Senior Advisor in the international region of the Medicines Quality Organisation (MQO), responsible for the creation and maintenance of the PSMFs and PSSFs within Lilly. Previously she created and implemented the Lilly pharmacovigilance compliance metrics processes including the late ICSR metrics process. She has participated and led many GVP inspections in both front and back rooms. Pat is the Co-Chair of the EFPIA International Pharmacovigilance Group (IPVG) and also participates in the Middle East/Africa and CIS work streams within IPVG.